Literature DB >> 31255705

Structural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins.

Samuel Jurado1, Mario Cano-Muñoz1, Bertrand Morel1, Sara Standoli1, Elisabetta Santarossa1, Christiane Moog2, Sylvie Schmidt2, Géraline Laumond2, Ana Cámara-Artigas3, Francisco Conejero-Lara4.   

Abstract

Development of effective inhibitors of the fusion between HIV-1 and the host cell membrane mediated by gp41 continues to be a grand challenge due to an incomplete understanding of the molecular and mechanistic details of the fusion process. We previously developed single-chain, chimeric proteins (named covNHR) that accurately mimic the N-heptad repeat (NHR) region of gp41 in a highly stable coiled-coil conformation. These molecules bind strongly to peptides derived from the gp41 C-heptad repeat (CHR) and are potent and broad HIV-1 inhibitors. Here, we investigated two covNHR variants differing in two mutations, V10E and Q123R (equivalent to V38E and Q40R in gp41 sequence) that reproduce the effect of HIV-1 mutations associated with resistance to fusion inhibitors, such as T20 (enfuvirtide). A detailed calorimetric analysis of the binding between the covNHR proteins and CHR peptides (C34 and T20) reveals drastic changes in affinity due to the mutations as a result of local changes in interactions at the site of T20 resistance. The crystallographic structure of the covNHR:C34 complex shows a virtually identical CHR-NHR binding interface to that of the post-fusion structure of gp41 and underlines an important role of buried interfacial water molecules in binding affinity and in development of resistance against CHR peptides. Despite the great difference in affinity, both covNHR variants demonstrate strong inhibitory activity for a wide variety of HIV-1 strains. These properties support the high potential of these covNHR proteins as new potent HIV-1 inhibitors. Our results may guide future inhibition approaches.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  binding; calorimetry; envelope glycoprotein; fusion inhibitor; x-ray crystallography

Mesh:

Substances:

Year:  2019        PMID: 31255705     DOI: 10.1016/j.jmb.2019.06.022

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  4 in total

1.  Fejerlectin, a Lectin-like Peptide from the Skin of Fejervarya limnocharis, Inhibits HIV-1 Entry by Targeting Gp41.

Authors:  Weichen Xiong; Chenliang Zhou; Shuwen Yin; Jinwei Chai; Baishuang Zeng; Jiena Wu; Yibin Li; Lin Li; Xueqing Xu
Journal:  ACS Omega       Date:  2021-02-24

2.  Extremely Thermostabilizing Core Mutations in Coiled-Coil Mimetic Proteins of HIV-1 gp41 Produce Diverse Effects on Target Binding but Do Not Affect Their Inhibitory Activity.

Authors:  Mario Cano-Muñoz; Samuele Cesaro; Bertrand Morel; Julie Lucas; Christiane Moog; Francisco Conejero-Lara
Journal:  Biomolecules       Date:  2021-04-12

3.  Conformational Stabilization of Gp41-Mimetic Miniproteins Opens Up New Ways of Inhibiting HIV-1 Fusion.

Authors:  Mario Cano-Muñoz; Julie Lucas; Li-Yun Lin; Samuele Cesaro; Christiane Moog; Francisco Conejero-Lara
Journal:  Int J Mol Sci       Date:  2022-03-03       Impact factor: 5.923

4.  Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity.

Authors:  Mario Cano-Muñoz; Daniel Polo-Megías; Ana Cámara-Artigas; José A Gavira; María J López-Rodríguez; Géraldine Laumond; Sylvie Schmidt; Julien Demiselle; Seiamak Bahram; Christiane Moog; Francisco Conejero-Lara
Journal:  Int J Biol Macromol       Date:  2022-10-08       Impact factor: 8.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.